Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

  Email address:

IPO/Stock Watch

Market trends, bell-weather stocks, filings and IPOs...

BeiGene Gets Green Light for $3 Billion Shanghai STAR IPO

Shanghai AoHua Endoscope Raises $117 Million in IPO; Trades 71% Higher

Clover Bio Stages $260 Million Hong Kong IPO for Vaccine and Oncology Candidates

LianBio Completes $325 Million US IPO to Support China In-Licensing Program

Microtech Medical Stages $233 Million Hong Kong IPO for Diabetes Devices

ChinaBio Event
Shanghai and Digital
May 10-14, 2021
ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes

Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China